EcoDrugPlus

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSFHEG00000015346
Gene Symbol: LOC105927414
3 Cross references
203 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2a-Like

Ensembl ID : ENSFHEG00000012781
Gene Symbol: LOC105940035
2 Cross references
225 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSFHEG00000016264
Gene Symbol: LOC105934932
2 Cross references
213 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 3b-Like

Ensembl ID : ENSFHEG00000018592
Gene Symbol: LOC105935350
2 Cross references
227 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSFHEG00000007455
Gene Symbol: GRIA2B
2 Cross references
254 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSFHEG00000010625
Gene Symbol: GRIN2BB
1 Cross references
255 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSFHEG00000019216
Gene Symbol: LOC105920964
3 Cross references
236 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSFHEG00000010591
Gene Symbol: LOC105916521
2 Cross references
225 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSFHEG00000010034
Gene Symbol: GSK3A
3 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSFHEG00000016694
Gene Symbol: GSK3B
3 Cross references
208 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSFHEG00000008025
Gene Symbol: LOC105920118
3 Cross references
181 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor

Ensembl ID : ENSFHEG00000013590
Gene Symbol: LOC105921780
2 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).